GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Accounts Payables (2021 - 2026)

GH Research (GHRS) posted quarterly Accounts Payables of $3.8 million for Q4 2025, up 0.86% year-over-year from $3.7 million in Q4 2024, and down 1.67% quarter-over-quarter from $3.8 million in Q3 2025.

Analysis

GH Research (GHRS) Accounts Payables (2021 - 2026) Analysis & Trends

GH Research's Accounts Payables history runs 5 years deep, the most recent figure standing at $3.8 million for Q4 2025.

  • In Q4 2025, Accounts Payables rose 0.86% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (up 0.86% YoY), while the FY2025 annual figure was $3.8 million, up 0.86% from the prior year.
  • Accounts Payables for Q4 2025 stood at $3.8 million, down from $3.8 million in the prior quarter.
  • The five-year high for Accounts Payables was $4.8 million in Q1 2025, with the low at $399000.0 in Q4 2021.
  • The 5-year median for Accounts Payables is $2.9 million (2023), against an average of $2.7 million.
  • The sharpest annual moves came in 2022 and 2024: Accounts Payables surged 368.17% in 2022, then retreated 11.68% in 2024.
  • GH Research's Accounts Payables stood at $399000.0 in 2021, then soared by 368.17% to $1.9 million in 2022, then soared by 86.83% to $3.5 million in 2023, then grew by 7.19% to $3.7 million in 2024, then gained by 0.86% to $3.8 million in 2025.
  • Business Quant data shows GHRS's Accounts Payables at $3.8 million in Q4 2025, $3.8 million in Q3 2025, and $3.4 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 GH Research 1.72 Bn 1.36 Bn - 5.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.93 Mn
Mar 31, 2026 5.21 Mn
Dec 31, 2025 3.77 Mn
Sep 30, 2025 3.84 Mn
Jun 30, 2025 3.45 Mn
Mar 31, 2025 4.77 Mn
Dec 31, 2024 3.74 Mn
Sep 30, 2024 2.95 Mn
Jun 30, 2024 2.57 Mn
Mar 31, 2024 3.55 Mn
Dec 31, 2023 3.49 Mn
Sep 30, 2023 2.71 Mn
Jun 30, 2023 2.91 Mn
Mar 31, 2023 2.93 Mn
Dec 31, 2022 1.87 Mn
Sep 30, 2022 1.75 Mn
Jun 30, 2022 1.71 Mn
Mar 31, 2022 1.55 Mn
Dec 31, 2021 883,000.00
Sep 30, 2021 1.21 Mn